β-Catenin plays a key role in metastasis of human hepatocellular carcinoma

Oncology Reports

Volumn 26, Issue 2, 2011, Pages 415-422

  Lai, Tung Yuan ^a,b   Su, Cheng Chuan ^c,d   Kuo, Wei Wen ^a   Yeh, Yu Lan ^e   Kuo, Wu Hsien ^f   Tsai, Fuu Jen ^a   Tsai, Chang Hai ^g   Weng, Yi Jiun ^a   Huang, Chih Yang ^a,g   Chen, Li Men ^f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

Catenin; HA22T; Hepatocellular carcinoma; Invasion; Migration

Indexed keywords

BETA CATENIN; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BETA CATENIN GENE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL NUCLEUS; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IL 8 GENE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; METASTASIS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79958189588     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1323     Document Type: Article

References (30)

1. Pisani P, Parkin DM, Bray F and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999.
2. Yuan RH, Jeng YM, Chen HL, Hsieh FJ, Yang CY, Lee PH and Hsu HC: Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis. Clin Cancer Res 11: 2568-2575, 2005.
3. Sporn MB: The war on cancer. Lancet 347: 1377-1381, 1996.
4. Aplin AE, Howe A, Alahari SK and Juliano RL: Signal transduction and signal modulation by cell adhesion receptors. The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50: 197-263, 1998.
5. Rimm DL, Koslov ER, Kebriaei P, Cianci CD and Morrow JS: Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA 92: 8813-8817, 1995.
6. Christofori G and Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76, 1999. (Pubitemid 29346577)
7. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
8. Ban KC, Singh H, Krishnan R and Seow HF: GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma. Cancer Lett 199: 201-208, 2003. (Pubitemid 37297713)
9. Lucero OM, Dawson DW, Moon RT and Chien AJ: A re-evaluation of the 'oncogenic' nature of Wnt/beta-catenin signaling in melanoma and other cancers. Curr Oncol Rep 12: 314-318, 2010.
10. Chan EF, Gat U, McNiff JM and Fuchs E: A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 21: 410-413, 1999. (Pubitemid 29159579)
11. 2+ pathways. Oncogene 18: 7860-7872, 1999. (Pubitemid 30066232)
12. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
13. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
14. De La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C: Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851, 1998. (Pubitemid 28350577)
15. Takigawa Y and Brown AM: Wnt signaling in liver cancer. Curr Drug Targets 9: 1013-1024, 2008.
16. Devereux TR, Anna CH, Foley JF, White CM, Sills RC and Barrett JC: Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 18: 4726-4733, 1999. (Pubitemid 29417748)
17. Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, London SJ and Taylor JA: CFNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol Carcinog 31: 68-73, 2001.
18. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL and Peng SY: Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157: 763-770, 2000.
19. Li YJ, Wei ZM, Meng YX and Ji XR: Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 11: 2117-2123, 2005.
20. Joo M, Lee HK and Kang YK: Expression of beta-catenin in hepatocellular carcinoma in relation to tumor cell proliferation and cyclinD1 expression. J Korean Med Sci 18: 211-217, 2003. (Pubitemid 38011287)
21. Liu CJ, Cheng YC, Lee KW, Hsu HH, Chu CH, Tsai FJ, Tsai CH, Chu CY, Liu JY, Kuo WW and Huang CY: Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Mol Cell Biochem 313: 167-178, 2008.
22. Masuda T, Beppu T, Ishiko T, Horino K, Baba Y, Mizumoto X Hayashi H, Okabe H, Horlad H, Doi K, Okabe K, Takamori H, Hirota M, Iyama K and Baba H: Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg 15: 589-595, 2008.
23. Bar-Eli M: Pole of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 67: 12-18, 1999.
24. Takeda A, Stoeltzing O, Ahmad SA, Reinmuth N, Liu W, Parikh A, Fan F, Akagi M and Ellis LM: Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol 9: 610-616, 2002. (Pubitemid 34857976)
25. Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305, 1997. (Pubitemid 28023954)
26. Peifer M and Polakis P: Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609, 2000. (Pubitemid 30127755)
27. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T and Nakamura Y: Activation of the beta-catenin gene in primary hepatocellular carcinoma by somatic alterations involving exon 3. Cancer Res 58: 2524-2527, 1998. (Pubitemid 28275419)
28. Cui J, Zhou XD, Liu YK, Tang ZY and Zile MH: Abnormal β-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China. World J Gastroenterol 7: 542-546, 2001. (Pubitemid 32780667)
29. Wang W, Xue L and Wang P: Prognostic value of beta-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma. Med Oncol: Feb 9, 2010 (Epub ahead of print).
30. Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW and Sood AK: Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem 285: 35462-35470, 2010.